[1]
|
Johnson, P.J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H.L., O’Beirne, J., Fox, R., Skowronska, A., Palmer, D., Yeo, W., Mo, F., Lai, P., Iñarrairaegui, M., Chan, S.L., Sangro, B., Miksad, R., Tada, T., Kumada, T. and Toyoda, H. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evi-dence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558.
https://doi.org/10.1200/JCO.2014.57.9151
|
[2]
|
Demirtas, C.O., D’Alessio, A., Rimassa, L., et al. (2021) ALBI Grade: Evidence for an Improved Model for Liver Functional Estimation in Patients with Hepatocellular Carcinoma. JHEP Reports, 3, Article ID: 100347.
https://doi.org/10.1016/j.jhepr.2021.100347
|
[3]
|
Xu, Y.X., Wang, Y.B., Tan, Y.L., et al. (2019) Prognostic Value of Pretreatment Albumin to Bilirubin Ratio in Patients with Hepatocellular Cancer: A Meta-Analysis. Medicine (Balti-more), 98, e14027.
https://doi.org/10.1097/MD.0000000000014027
|
[4]
|
Matsue, Y., Kagiyama, N., Yamaguchi, T., et al. (2020) Clinical and Prognostic Values of ALBI Score in Patients with Acute Heart Failure. Heart, Lung and Circulation, 29, 1328-1337. https://doi.org/10.1016/j.hlc.2019.12.003
|
[5]
|
Sakamaki, A., Takamura, M., Sakai, N., Watanabe, Y., et al. (2022) Longitudinal Increase in Albumin-Bilirubin Score Is Associated with Non-Malignancy-Related Mortality and Quality of Life in Patients with Liver Cirrhosis. PLOS ONE, 17, e0263464. https://doi.org/10.1371/journal.pone.0263464
|
[6]
|
Garcia-Martinez, R., Caraceni, P., Bernardi, M., et al. (2013) Albumin: Pathophysiologic Basis of Its Role in the Treatment of Cirrhosis and Its Complications. Hepatology, 58, 1836-1846. https://doi.org/10.1002/hep.26338
|
[7]
|
Vítek, L. (2020) Bilirubin as a Signaling Molecule. Medicinal Research Reviews, 40, 1335-1351.
https://doi.org/10.1002/med.21660
|
[8]
|
Liu, D., Yu, Q., Li, Z., et al. (2021) UGT1A1 Dysfunction Increases Liver Burden and Aggravates Hepatocyte Damage Caused by Long-Term Bilirubin Metabolism Disorder. Biochemical Phar-macology, 190, Article ID: 114592.
https://doi.org/10.1016/j.bcp.2021.114592
|
[9]
|
Kanda, M., Tanaka, C., Kobayashi, D., et al. (2018) Preoperative Albumin-Bilirubin Grade Predicts Recurrences after Radical Gastrectomy in Patients with pT2-4 Gastric Cancer. World Journal of Surgery, 42, 773-781.
https://doi.org/10.1007/s00268-017-4234-x
|
[10]
|
Matsukane, R., Watanabe, H., Hata, K., Suetsugu, K., et al. (2021) Prognostic Significance of Pre-Treatment ALBI Grade in Advanced Non-Small Cell Lung Cancer Receiving Immune Checkpoint Therapy. Scientific Reports, 11, Article No. 15057. https://doi.org/10.1038/s41598-021-94336-9
|
[11]
|
Gonsalkorala, E.S., Cannon, M.D., Lim, T.Y., et al. (2019) Non-Invasive Markers (ALBI and APRI) Predict Pregnancy Outcomes in Women with Chronic Liver Disease. American Journal of Gastroenterology, 114, 267-275.
https://doi.org/10.1038/s41395-018-0181-x
|
[12]
|
Jagdish, R.K., Maras, J.S. and Sarin, S.K. (2021) Albumin in Advanced Liver Diseases: The Good and Bad of a Drug! Hepatology, 74, 2848-2862. https://doi.org/10.1002/hep.31836
|
[13]
|
Kawaguchi, T., Izumi, N., Charlton, M.R. and Sata, M. (2011) Branched-Chain Amino Acids as Pharmacological Nutrients in Chronic Liver Disease. Hepatology, 54, 1063-1070. https://doi.org/10.1002/hep.24412
|
[14]
|
Van Houten, B. (2015) Pulmonary Arterial Hypertension Is Associated with Oxidative Stress-Induced Genome Instability. American Journal of Respiratory and Critical Care Medicine, 192, 129-130.
https://doi.org/10.1164/rccm.201505-0904ED
|
[15]
|
Pang, Q., Liu, S.C., Wang, L.Y., Pan, H.D., et al. (2020) The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count. Cancer Management and Research, 12, 12811-12822. https://doi.org/10.2147/CMAR.S277013
|
[16]
|
Elshaarawy, O., Allam, N., Abdelsameea, E., Gomaa, A. and Waked, I. (2020) Platelet-Albumin-Bilirubin Score—A Predictor of Outcome of Acute Variceal Bleeding in Patients with Cirrho-sis. World Journal of Hepatology, 12, 99-107.
https://doi.org/10.4254/wjh.v12.i3.99
|
[17]
|
Kariyama, K., Nouso, K., Hiraoka, A., et al. (2020) EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis. Liver Cancer, 9, 734-743. https://doi.org/10.1159/000508971
|
[18]
|
Ananchuensook, P., Sriphoosanaphan, S., Suksawatamnauy, S., Siripon, N., et al. (2022) Validation and Prognostic Value of EZ-ALBI Score in Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Trans-Arterial Chemoembolization. BMC Gastroenterology, 22, Article No. 295. https://doi.org/10.1186/s12876-022-02366-y
|
[19]
|
Fang, T., Long, G., Wang, D., et al. (2021) A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure after Hepatectomy in HCC Patients. Frontiers in Oncology, 11, Article ID: 667496.
https://doi.org/10.3389/fonc.2021.667496
|
[20]
|
Park, H.J., Seo, K.I., Kim, S.J., Lee, S.K., et al. (2021) Effective-ness of Albumin-Bilirubin Score as a Predictor of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carci-noma. The Korean Journal of Gastroenterology, 77, 115-122. https://doi.org/10.4166/kjg.2020.148
|
[21]
|
Hiraoka, A., Kumada, T., Kudo, M., et al. (2017) Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifi-cations. Liver Cancer, 6, 204-215. https://doi.org/10.1159/000452846
|
[22]
|
Hsieh, Y.C., Lee, K.C., Wang, Y.W., et al. (2018) Correlation and Prognostic Accuracy between Noninvasive Liver Fibrosis Markers and Portal Pressure in Cirrhosis: Role of ALBI Score. PLOS ONE, 13, e0208903.
https://doi.org/10.1371/journal.pone.0208903
|
[23]
|
Zhang, C.H., Ni, X.C., Chen, B.Y., Qiu, S.J., et al. (2019) Combined Preoperative Albumin-Bilirubin (ALBI) and Serum γ-Glutamyl Transpeptidase (GGT) Predicts the Outcome of Hepatocellular Carcinoma Patients Following Hepatic Resection. Journal of Cancer, 10, 4836-4845. https://doi.org/10.7150/jca.33877
|
[24]
|
Aslan, S., Eryuruk, U., Tasdemir, M.N. and Cakir, I.M. (2022) Determining the Efficacy of Functional Liver Imaging Score (FLIS) Obtained from Gadoxetic Acid-Enhanced MRI in Patients with Chronic Liver Disease and Liver Cirrhosis: The Relationship between Albumin-Bilirubin (ALBI) Grade and FLIS. Ab-dominal Radiology (NY), 47, 2325-2334.
https://doi.org/10.1007/s00261-022-03557-7
|
[25]
|
Takatsu, Y., Kobayashi, S., Miyati, T. and Shiozaki, T. (2016) Hepatobiliary Phase Images Using Gadolinium-Ethoxybenzyl-Diethylenetriamine Penta-Acetic Acid-Enhanced MRI as an Imaging Surrogate for the Albumin-Bilirubin Grading System. European Journal of Radiology, 85, 2206-2210.
https://doi.org/10.1016/j.ejrad.2016.10.010
|
[26]
|
王敏哲. 钆塞酸二钠增强MRI直方图参数评估肝脏储备功能临床初探[D]: [硕士学位论文]. 兰州: 兰州大学, 2022. https://doi.org/10.27204/d.cnki.glzhu.2022.000538
|
[27]
|
Llovet, J.M., Brú, C. and Bruix, J. (1999) Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification. Seminars in Liver Disease, 19, 329-338. https://doi.org/10.1055/s-2007-1007122
|
[28]
|
党晓卫, 沈东启, 李路豪, 刘兆臣, 李素新, 王培举, 杨净, 张跃辉. 血小板-白蛋白-胆红素评分在布-加综合征并发上消化道出血短期预后评估中的应用价值[J]. 中华肝胆外科杂志, 2022, 28(4): 264-269.
|
[29]
|
赵首捷, 杨振宇, 雷世雄, 谭凯, 刘雷. Child-Pugh评分和ALBI分级对BCLC-B期肝癌生存预后预测价值比较[J]. 中华肝脏外科手术学电子杂志, 2021, 10(1): 38-42.
|
[30]
|
Wang, J., Zhang, Z., Yan, X., et al. (2019) Albumin-Bilirubin (ALBI) as an Accurate and Simple Prognostic Score for Chronic Hepatitis B-Related Liver Cirrhosis. Digestive and Liver Disease, 51, 1172-1178.
https://doi.org/10.1016/j.dld.2019.01.011
|
[31]
|
Chan, A.W.H., Chong, C.C.N., Mo, F.K.F., et al. (2016) Applica-bility of Albumin-Bilirubin-Based Japan Integrated Staging Score in Hepatitis B-Associated Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology, 31, 1766-1772. https://doi.org/10.1111/jgh.13339
|
[32]
|
Zou, H., Yang, X., Li, Q.L., et al. (2018) A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocel-lular Carcinoma Patients. Digestive Diseases, 36, 236-243. https://doi.org/10.1159/000486590
|